IG
GILD icon

IFS Group’s Gilead Sciences GILD Stock Holding History

IFS Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$254K Buy
+2,287
New +$260K 0.22% 116

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

IFS Group's GILD Position: Q3 2025 in Review

IFS Group opened a new position in Gilead Sciences (GILD) in Q3 2025: 2,287 shares worth $254K. The stake represents 0.22% of the portfolio and ranks #116 among its holdings.

2,032 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • IFS Group held 2,287 shares of Gilead Sciences worth $254K as of Q3 2025.
  • Gilead Sciences was a new IFS Group position in Q3 2025.
  • Gilead Sciences made up 0.22% of IFS Group's portfolio in Q3 2025, its #116 holding.
  • 2,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on IFS Group's 13F filing for Q3 2025, filed 10 Nov 2025.